Fund shareholders of Ultragenyx Pharmaceutical Inc
ISIN US90400D1081 · United States · LEI 529900EV44GVDN1DCX77
- Fund shareholders
- 244
- Of which ETFs
- 50 194 other funds
- Value held
- 587.2M $ 6.7M SEK
- Share of capital
- 27.2 % of 98.6M shares on Jul 31, 2026
244 funds hold this company. This table lists the 243 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 3,107,837 | 65.1M $ | 0.88 % | 3.15 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,935,570 | 61.5M $ | 0.00 % | 2.98 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,114,864 | 44.3M $ | 0.03 % | 2.15 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 1,906,644 | 47.1M $ | 0.22 % | 1.93 % | as of Apr 30, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,189,629 | 24.9M $ | 0.06 % | 1.21 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,079,869 | 22.6M $ | 0.03 % | 1.10 % | as of Mar 31, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 811,441 | 17M $ | 0.21 % | 0.82 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS | 782,649 | 16.4M $ | 0.16 % | 0.79 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 680,286 | 14.3M $ | 0.18 % | 0.69 % | as of Mar 31, 2026 ↗ |
| Touchstone Funds Group Trust-Touchstone Sands Capital Select Growth Fund Touchstone Funds Group Trust | 650,491 | 13.6M $ | 0.71 % | 0.66 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 618,129 | 12.9M $ | 0.07 % | 0.63 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 599,685 | 14M $ | 0.02 % | 0.61 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 469,481 | 11M $ | 0.05 % | 0.48 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 420,590 | 9.8M $ | 0.02 % | 0.43 % | as of Feb 28, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 379,627 | 8M $ | 0.01 % | 0.39 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 351,786 | 7.4M $ | 0.02 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 341,505 | 8.4M $ | 0.02 % | 0.35 % | as of Apr 30, 2026 ↗ |
| Small Cap Core Fund John Hancock Investment Trust | 303,604 | 7.5M $ | 0.38 % | 0.31 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 274,749 | 6.4M $ | 0.00 % | 0.28 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 261,089 | 6.1M $ | 0.03 % | 0.26 % | as of Feb 28, 2026 ↗ |
| Nuveen Quant Small/Mid Cap Equity Fund TIAA-CREF Funds | 248,080 | 6.1M $ | 0.24 % | 0.25 % | as of Apr 30, 2026 ↗ |
| AQR Managed Futures Strategy Fund AQR Funds | 244,513 | 5.1M $ | 0.17 % | 0.25 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 239,290 | 5M $ | 0.00 % | 0.24 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 236,751 | 5M $ | 0.20 % | 0.24 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 232,319 | 4.9M $ | 0.04 % | 0.24 % | as of Mar 31, 2026 ↗ |
| AMG GW&K Small Cap Core Fund AMG Funds | 220,347 | 4.6M $ | 0.68 % | 0.22 % | as of Mar 31, 2026 ↗ |
| AQR Equity Market Neutral Fund AQR Funds | 208,429 | 4.4M $ | 0.13 % | 0.21 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 190,069 | 4M $ | 0.05 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 186,183 | 4.6M $ | 0.16 % | 0.19 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 180,996 | 4.2M $ | 0.09 % | 0.18 % | as of Feb 27, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 180,636 | 4.2M $ | 0.00 % | 0.18 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 178,057 | 4.4M $ | 0.85 % | 0.18 % | as of Apr 30, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 175,165 | 4.1M $ | 0.20 % | 0.18 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 151,480 | 3.5M $ | 0.01 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 145,703 | 3.4M $ | 0.00 % | 0.15 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 136,329 | 2.9M $ | 0.00 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 131,220 | 3.2M $ | 0.01 % | 0.13 % | as of Apr 30, 2026 ↗ |
| NVIT Jacobs Levy Large Cap Growth Fund Nationwide Variable Insurance Trust | 113,788 | 2.4M $ | 0.52 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 112,634 | 2.4M $ | 0.07 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 108,067 | 2.7M $ | 0.26 % | 0.11 % | as of Apr 30, 2026 ↗ |
| ALGER WEATHERBIE SPECIALIZED GROWTH FUND ALGER FUNDS | 104,835 | 2.6M $ | 0.92 % | 0.11 % | as of Apr 30, 2026 ↗ |
| SMALL COMPANY GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 92,881 | 1.9M $ | 0.14 % | 0.09 % | as of Mar 31, 2026 ↗ |
| AMG GW&K Small Cap Growth Fund AMG Funds IV | 85,982 | 2.1M $ | 1.02 % | 0.09 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 85,792 | 1.8M $ | 0.08 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 83,707 | 2.1M $ | 1.31 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Motley Fool Small-Cap Growth ETF RBB Fund, Inc. | 83,491 | 2M $ | 2.82 % | 0.08 % | as of Feb 28, 2026 ↗ |
| U.S. Strategic Equity Fund RUSSELL INVESTMENT CO | 78,033 | 1.9M $ | 0.06 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 70,000 | 1.5M $ | 0.22 % | 0.07 % | as of Mar 31, 2026 ↗ |
| AQR Managed Futures Strategy HV Fund AQR Funds | 69,901 | 1.5M $ | 0.12 % | 0.07 % | as of Mar 31, 2026 ↗ |
| AMG GW&K Small Cap Value Fund AMG Funds | 68,191 | 1.4M $ | 0.71 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 67,524 | 1.7M $ | 0.01 % | 0.07 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 67,359 | 1.7M $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 64,700 | 1.6M $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| MFS New Discovery Series MFS VARIABLE INSURANCE TRUST | 63,320 | 1.3M $ | 0.19 % | 0.06 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 61,839 | 1.3M $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 59,452 | 1.5M $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 59,264 | 1.4M $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 59,101 | 1.5M $ | 1.49 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 58,689 | 1.4M $ | 0.01 % | 0.06 % | as of Feb 28, 2026 ↗ |
| LVIP Nomura SMID Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 57,257 | 1.2M $ | 0.19 % | 0.06 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 55,107 | 1.4M $ | 0.75 % | 0.06 % | as of Apr 30, 2026 ↗ |
| First Trust Small Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 54,688 | 1.4M $ | 0.13 % | 0.06 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 54,669 | 1.1M $ | 0.07 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Trust John Hancock Variable Insurance Trust | 54,548 | 1.1M $ | 0.40 % | 0.06 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 52,770 | 1.1M $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 52,561 | 1.1M $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 49,849 | 1.2M $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 47,081 | 1.2M $ | 0.04 % | 0.05 % | as of Apr 30, 2026 ↗ |
| PACE Small/Medium Co Growth Equity Investments PACE SELECT ADVISORS TRUST | 46,199 | 1.1M $ | 0.45 % | 0.05 % | as of Apr 30, 2026 ↗ |
| NORTH SQUARE DYNAMIC SMALL CAP FUND Exchange Place Advisors Trust | 44,850 | 1M $ | 0.15 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Small Cap Value Fund Goldman Sachs Trust | 44,488 | 1M $ | 0.11 % | 0.05 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage SMID Cap Fund, Inc. BlackRock Advantage SMID Cap Fund, Inc. | 44,291 | 927.9K $ | 0.12 % | 0.04 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 44,224 | 926.5K $ | 0.06 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Tax Managed Small/Mid Cap Fund Bridge Builder Trust | 44,123 | 924.4K $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 42,666 | 893.9K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 42,300 | 886.2K $ | 0.12 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 41,801 | 875.7K $ | 0.03 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 39,779 | 930.4K $ | 1.78 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 39,736 | 981.1K $ | 0.03 % | 0.04 % | as of Apr 30, 2026 ↗ |
| M Capital Appreciation Fund M FUND INC | 39,179 | 820.8K $ | 0.31 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Touchstone ETF Trust-Touchstone Sands Capital US Select Growth ETF Touchstone ETF Trust | 37,918 | 794.4K $ | 0.72 % | 0.04 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Growth Fund BlackRock Funds | 36,804 | 771K $ | 0.12 % | 0.04 % | as of Mar 31, 2026 ↗ |
| JPMorgan BetaBuilders U.S. Small Cap Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 34,325 | 847.5K $ | 0.12 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2500 ETF iShares Trust | 34,238 | 717.3K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 34,041 | 713.2K $ | 0.53 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 33,790 | 834.3K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Global Småbolag Index Criteria Handelsbanken Fonder AB | 33,523 | 6.7M SEK | 0.02 % | 0.03 % | as of Mar 31, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 33,176 | 695K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Small Cap Growth Fund Goldman Sachs Trust | 32,533 | 760.9K $ | 0.18 % | 0.03 % | as of Feb 28, 2026 ↗ |
| iShares ESG Aware MSCI USA Small-Cap ETF iShares Trust | 32,189 | 752.9K $ | 0.03 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 31,976 | 747.9K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Nomura Smid Cap Core Fund IVY FUNDS | 31,107 | 651.7K $ | 0.19 % | 0.03 % | as of Mar 31, 2026 ↗ |
| HARTFORD SMALL CAP GROWTH HLS FUND HARTFORD SERIES FUND INC | 30,525 | 639.5K $ | 0.12 % | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap Growth ETF iShares Trust | 28,026 | 692K $ | 0.07 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 26,120 | 644.9K $ | 1.09 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 25,362 | 531.3K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 24,923 | 522.1K $ | 0.05 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD MARKET NEUTRAL FUND VANGUARD MONTGOMERY FUNDS | 24,539 | 514.1K $ | 0.12 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 24,057 | 594K $ | 0.06 % | 0.02 % | as of Apr 30, 2026 ↗ |
| GROWTH EQUITY FUND GuideStone Funds | 23,151 | 485K $ | 0.04 % | 0.02 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Motley Fool Small-Cap Growth ETF RBB Fund, Inc. | 2.82 % | as of Feb 28, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 1.78 % | as of Feb 28, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 1.49 % | as of Apr 30, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 1.31 % | as of Apr 30, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.16 % | as of Sep 30, 2025 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.09 % | as of Apr 30, 2026 ↗ |
| AMG GW&K Small/Mid Cap Growth Fund AMG Funds IV | 1.03 % | as of Apr 30, 2026 ↗ |
| AMG GW&K Small Cap Growth Fund AMG Funds IV | 1.02 % | as of Apr 30, 2026 ↗ |
| ALGER WEATHERBIE SPECIALIZED GROWTH FUND ALGER FUNDS | 0.92 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.88 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 242 | -1 | 26,776,226 | -16.9 % |
| 2026Q1 | 243 | -58 | 32,236,939 | -11.4 % |
| 2025Q4 | 301 | -20 | 36,389,700 | +10.4 % |
| 2025Q3 | 321 | +29 | 32,953,092 | +4.9 % |
| 2025Q2 | 292 | -6 | 31,414,853 | -0.3 % |
| 2025Q1 | 298 | -1 | 31,519,019 | -8.6 % |
| 2024Q4 | 299 | +9 | 34,468,447 | +3.7 % |
| 2024Q3 | 290 | 0 | 33,240,233 | +4.5 % |
| 2024Q2 | 290 | +16 | 31,800,888 | +0.9 % |
| 2024Q1 | 274 | -3 | 31,522,849 | +0.6 % |
| 2023Q4 | 277 | 31,337,170 |
Institutional managers
287 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 7,299,598 | 152.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,021,441 | 105.2M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 4,578,024 | 95.9M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 3,648,795 | 76.4M $ | as of Mar 31, 2026 |
| SANDS CAPITAL MANAGEMENT, LLC | 3,214,533 | 67.3M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 3,145,888 | 65.9M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,640,812 | 55.3M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 2,380,000 | 49.9M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 2,257,671 | 47.3M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 2,205,820 | 46.2M $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,191,182 | 45.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,115,491 | 44.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,849,391 | 38.8M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,772,184 | 37.1M $ | as of Mar 31, 2026 |
| GW&K Investment Management, LLC | 1,615,426 | 33.8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,500,528 | 31.4M $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,431,071 | 30M $ | as of Mar 31, 2026 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,426,834 | 29.9M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,261,018 | 26.4M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 1,218,773 | 25.5M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 1,165,557 | 24.4M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 1,096,182 | 23M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,046,546 | 21.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 914,760 | 19.2M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 893,295 | 18.7M $ | as of Mar 31, 2026 |
Declared shareholders of Ultragenyx Pharmaceutical Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Portfolio Management | 5.50 % | 5,410,208 | as of Mar 31, 2026 · SCHEDULE 13G |
| STATE STREET CORPORATION | 5.10 % | 5,021,441 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Ultragenyx Pharmaceutical Inc". https://titelia.com/en/stocks/ultragenyx-pharmaceutical-inc-US90400D1081